Advertisement
Screener

VISTAGEN THERAPEUTICS, INC. (VTGN) Interest Expense

2.8 / 5 stars · 68/120 Roast Me

VISTAGEN THERAPEUTICS, INC. Interest Expense

VISTAGEN THERAPEUTICS, INC. (VTGN) reported Interest Expense of -$1.50 thousand for the 3-month period ending 2019-12-31, per its 10-Q filed 2020-02-13.

Discontinued › Expense Statement

us-gaap:InterestExpense · last filed 2020-02-13

  • VISTAGEN THERAPEUTICS, INC. interest expense for the quarter ending 2019-12-31 was -$1.50K, a 183.33% decline year-over-year.
  • VISTAGEN THERAPEUTICS, INC. interest expense for the quarter ending 2019-09-30 was -$15.40K, a 631.03% decline year-over-year.
  • VISTAGEN THERAPEUTICS, INC. interest expense for the quarter ending 2019-03-31 was $1.00K, a 0.00% change year-over-year.
  • VISTAGEN THERAPEUTICS, INC. interest expense for the quarter ending 2018-12-31 was $1.80K, a 10.00% decline year-over-year.
  • VISTAGEN THERAPEUTICS, INC. interest expense for fiscal 2019 was $8.00K, a 10.11% decline from fiscal 2018.
  • VISTAGEN THERAPEUTICS, INC. interest expense for fiscal 2018 was $8.90K, a 93.48% increase from fiscal 2017.
  • VISTAGEN THERAPEUTICS, INC. interest expense for fiscal 2017 was $4.60K, a 99.40% decline from fiscal 2016.
  • VISTAGEN THERAPEUTICS, INC. interest expense for fiscal 2016 was $770.80K, a 83.05% decline from fiscal 2015.
Period endInterest Expense 3 monthInterest Expense 3 month as first filedInterest Expense 6 monthInterest Expense 6 month as first filedInterest Expense 9 monthInterest Expense 9 month as first filedInterest Expense 12 monthInterest Expense 12 month as first filedInterest Expense 157 monthInterest Expense 160 monthInterest Expense 163 monthInterest Expense 166 monthInterest Expense 169 monthInterest Expense 172 monthInterest Expense 175 monthInterest Expense 178 monthInterest Expense 181 monthInterest Expense 184 month
2019-12-31-$1.50K
10-Q · filed 2020-02-13
-$16.90K
derived: sum of 2 quarters · filed 2020-02-13
-$33.40K
10-Q · filed 2020-02-13
2019-09-30-$15.40K
10-Q · filed 2019-11-07
-$31.90K
10-Q · filed 2019-11-07
2019-03-31$1.00K
10-K · filed 2019-06-25
$2.80K
derived: sum of 2 quarters · filed 2020-02-13
$5.70K
derived: sum of 3 quarters · filed 2020-02-13
$8.00K
10-K · filed 2019-06-25
2018-12-31$1.80K
10-Q · filed 2020-02-13
$4.70K
derived: sum of 2 quarters · filed 2020-02-13
$6.80K
10-Q · filed 2020-02-13
$7.70K
derived: sum of 4 quarters · filed 2020-02-13
2018-09-30$2.90K
10-Q · filed 2019-11-07
$5.00K
10-Q · filed 2019-11-07
$5.90K
derived: sum of 3 quarters · filed 2019-11-07
$7.90K
derived: sum of 4 quarters · filed 2019-11-07
2018-06-30$2.00K
10-K · filed 2019-06-25
$2.10K
10-Q · filed 2018-08-14
$3.00K
derived: sum of 2 quarters · filed 2019-06-25
$5.00K
derived: sum of 3 quarters · filed 2019-06-25
$8.00K
derived: sum of 4 quarters · filed 2019-06-25
2018-03-31$1.00K
10-K · filed 2019-06-25
$3.00K
derived: sum of 2 quarters · filed 2019-06-25
$6.00K
derived: sum of 3 quarters · filed 2019-06-25
$8.90K
10-K · filed 2019-06-25
2017-12-31$2.00K
10-K · filed 2019-06-25
$5.00K
derived: sum of 2 quarters · filed 2019-06-25
$7.70K
10-Q · filed 2019-02-12
$9.00K
derived: sum of 4 quarters · filed 2019-06-25
2017-09-30$3.00K
10-K · filed 2019-06-25
$3.30K
10-Q · filed 2017-11-09
$5.70K
10-Q · filed 2018-10-29
$7.00K
derived: sum of 3 quarters · filed 2019-06-25
$8.00K
derived: sum of 4 quarters · filed 2019-06-25
2017-06-30$3.00K
10-K · filed 2019-06-25
$2.40K
10-Q · filed 2017-08-14
$4.00K
derived: sum of 2 quarters · filed 2019-06-25
$5.00K
derived: sum of 3 quarters · filed 2019-06-25
$6.00K
derived: sum of 4 quarters · filed 2019-06-25
2017-03-31$1.00K
10-K · filed 2018-06-26
$2.00K
derived: sum of 2 quarters · filed 2018-06-26
$3.00K
derived: sum of 3 quarters · filed 2018-06-26
$4.60K
10-K · filed 2018-06-26
2016-12-31$1.00K
10-K · filed 2018-06-26
$900.00
10-Q · filed 2017-02-13
$2.00K
derived: sum of 2 quarters · filed 2018-06-26
$3.70K
10-Q · filed 2018-02-12
$5.00K
derived: sum of 4 quarters · filed 2018-06-26
2016-09-30$1.00K
10-K · filed 2018-06-26
$1.40K
10-Q · filed 2016-11-14
$2.80K
10-Q · filed 2017-11-09
$4.00K
derived: sum of 3 quarters · filed 2018-06-26
$7.00K
derived: sum of 4 quarters · filed 2018-06-26
2016-06-30$2.00K
10-K · filed 2018-06-26
$1.40K
10-Q · filed 2016-08-12
$3.00K
derived: sum of 2 quarters · filed 2018-06-26
$6.00K
derived: sum of 3 quarters · filed 2018-06-26
$18.00K
derived: sum of 4 quarters · filed 2018-06-26
2016-03-31$1.00K
10-K · filed 2017-06-29
$4.00K
derived: sum of 2 quarters · filed 2017-06-29
$16.00K
derived: sum of 3 quarters · filed 2017-06-29
$770.80K
10-K · filed 2017-06-29
2015-12-31$3.00K
10-K · filed 2017-06-29
$2.50K
10-Q · filed 2016-02-16
$15.00K
derived: sum of 2 quarters · filed 2017-06-29
$769.80K
10-Q · filed 2017-02-13
$3.14M
derived: sum of 4 quarters · filed 2017-06-29
2015-09-30$12.00K
10-K · filed 2017-06-29
$12.20K
10-Q · filed 2015-11-16
$767.30K
10-Q · filed 2016-11-14
$3.13M
derived: sum of 3 quarters · filed 2017-06-29
$3.92M
derived: sum of 4 quarters · filed 2017-06-29
2015-06-30$755.00K
10-K · filed 2017-06-29
$755.10K
10-Q · filed 2015-08-14
$3.12M
derived: sum of 2 quarters · filed 2017-06-29
$3.91M
derived: sum of 3 quarters · filed 2017-06-29
$4.52M
derived: sum of 4 quarters · filed 2017-06-29
2015-03-31$2.37M
10-K · filed 2016-06-24
-$2.37M
10-K · filed 2015-06-29
$3.16M
derived: sum of 2 quarters · filed 2016-06-24
$3.76M
derived: sum of 3 quarters · filed 2016-06-24
$4.55M
10-K · filed 2016-06-24
2014-12-31$792.00K
10-K · filed 2016-06-24
$792.40K
10-Q · filed 2015-02-17
$1.40M
derived: sum of 2 quarters · filed 2016-06-24
$2.18M
10-Q · filed 2016-02-16
$1.68M
derived: sum of 4 quarters · filed 2016-06-24
2014-09-30$606.00K
10-K · filed 2016-06-24
$605.60K
10-Q · filed 2014-11-19
$1.39M
10-Q · filed 2015-11-16
$888.00K
derived: sum of 3 quarters · filed 2016-06-24
$527.00K
derived: sum of 4 quarters · filed 2016-06-24
2014-06-30$785.00K
10-K · filed 2016-06-24
-$784.90K
10-Q · filed 2014-08-12
$282.00K
derived: sum of 2 quarters · filed 2016-06-24
-$79.00K
derived: sum of 3 quarters · filed 2016-06-24
-$402.00K
derived: sum of 4 quarters · filed 2016-06-24
2014-03-31-$503.00K
10-K · filed 2015-06-29
-$864.00K
derived: sum of 2 quarters · filed 2015-06-29
-$1.19M
derived: sum of 3 quarters · filed 2015-06-29
$1.50M
10-K · filed 2015-06-29
-$1.50M
10-K · filed 2014-06-25
-$11.87M
10-K · filed 2014-06-25
2013-12-31-$361.00K
10-K · filed 2015-06-29
-$360.90K
10-Q · filed 2014-02-14
-$684.00K
derived: sum of 2 quarters · filed 2015-06-29
$1.00M
10-Q · filed 2015-02-17
-$1.00M
10-Q · filed 2014-02-14
-$1.31M
derived: sum of 4 quarters · filed 2015-06-29
-$11.36M
10-Q · filed 2014-02-14
2013-09-30-$323.00K
10-K · filed 2015-06-29
-$323.20K
10-Q · filed 2013-11-14
$639.60K
10-Q · filed 2014-11-19
-$639.60K
10-Q · filed 2013-11-14
-$948.00K
derived: sum of 3 quarters · filed 2015-06-29
-$1.18M
derived: sum of 4 quarters · filed 2015-06-29
-$11.00M
10-Q · filed 2013-11-14
2013-06-30-$316.00K
10-K · filed 2015-06-29
-$316.40K
10-Q · filed 2013-08-14
-$625.00K
derived: sum of 2 quarters · filed 2015-06-29
-$860.00K
derived: sum of 3 quarters · filed 2015-06-29
-$1.13M
derived: sum of 4 quarters · filed 2015-06-29
-$10.68M
10-Q · filed 2013-08-14
2013-03-31-$309.00K
10-K · filed 2014-06-25
-$544.00K
derived: sum of 2 quarters · filed 2014-06-25
-$818.00K
derived: sum of 3 quarters · filed 2014-06-25
-$920.70K
10-K · filed 2014-06-25
-$10.36M
10-K · filed 2013-07-18
2012-12-31-$235.00K
10-K · filed 2014-06-25
-$509.00K
derived: sum of 2 quarters · filed 2014-06-25
-$611.70K
10-Q · filed 2014-02-14
-$868.00K
derived: sum of 4 quarters · filed 2014-06-25
-$10.05M
10-Q · filed 2013-02-14
2012-09-30-$274.00K
10-K · filed 2014-06-25
-$273.50K
10-Q · filed 2012-11-14
-$376.30K
10-Q · filed 2013-11-14
-$633.00K
derived: sum of 3 quarters · filed 2014-06-25
-$1.09M
derived: sum of 4 quarters · filed 2014-06-25
-$9.82M
10-Q · filed 2012-11-14
2012-06-30-$103.00K
10-K · filed 2014-06-25
-$102.80K
10-Q · filed 2012-08-14
-$359.00K
derived: sum of 2 quarters · filed 2014-06-25
-$814.00K
derived: sum of 3 quarters · filed 2014-06-25
-$1.26M
derived: sum of 4 quarters · filed 2014-06-25
-$9.54M
10-Q · filed 2012-08-14
2012-03-31-$256.00K
10-K · filed 2013-07-18
-$711.00K
derived: sum of 2 quarters · filed 2013-07-18
-$1.16M
derived: sum of 3 quarters · filed 2013-07-18
-$1.89M
10-K · filed 2013-07-18
$1.89M
10-K · filed 2012-07-02
$9.44M
10-K · filed 2012-07-02
2011-12-31-$455.00K
10-K · filed 2013-07-18
$455.52K
10-Q · filed 2012-02-14
-$906.00K
derived: sum of 2 quarters · filed 2013-07-18
-$1.64M
10-Q · filed 2013-02-14
$1.64M
10-Q · filed 2012-02-14
-$768.66K
derived: sum of 4 quarters · filed 2013-07-18
$9.19M
10-Q · filed 2012-02-14
2011-09-30-$451.00K
10-K · filed 2013-07-18
$450.51K
10-Q · filed 2011-11-14
-$1.18M
10-Q · filed 2012-11-14
$1.18M
10-Q · filed 2011-11-14
-$313.66K
derived: sum of 3 quarters · filed 2013-07-18
$695.81K
derived: sum of 4 quarters · filed 2013-07-18
$8.73M
10-Q · filed 2011-11-14
2011-06-30-$731.00K
10-K · filed 2013-07-18
$731.61K
10-Q · filed 2011-08-22
$137.34K
derived: sum of 2 quarters · filed 2013-07-18
$1.15M
derived: sum of 3 quarters · filed 2013-07-18
$1.86M
derived: sum of 4 quarters · filed 2013-07-18
$8.28M
10-Q · filed 2011-08-22
2011-03-31$868.34K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-02
$1.88M
derived: sum of 2 quarters · filed 2012-07-02
$2.59M
derived: sum of 3 quarters · filed 2012-07-02
$3.12M
10-K · filed 2012-07-02
2010-12-31$1.01M
10-Q · filed 2012-02-14
$1.72M
derived: sum of 2 quarters · filed 2012-02-14
$2.25M
10-Q · filed 2012-02-14
2010-09-30$710.75K
10-Q · filed 2011-11-14
$1.24M
10-Q · filed 2011-11-14
2010-06-30$530.84K
10-Q · filed 2011-08-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
MUSTANG BIO, INC. (MBIO)United States$0.013B
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Tempest Therapeutics, Inc. (TPST)United States$0.013B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
BIOVIE INC. (BIVI)United States$0.012B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B